Close Menu

Researchers at the University of North Carolina, Chapel Hill, report in a paper published online in advance in Genome Research that the "tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription." More specifically, the team reports its generation of an experimental system in which they addressed "questions regarding the genomic mechanisms by which chimeric transcription factors cause cancer" using EWS-FLI and its parental transcription factor, FLI1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.